Specify Company / Ticker to Get the Summary
Dividend History MDWD
Dividend Analytics MDWD
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Mediwound Ltd
MDWDMediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel. Address: 42 Hayarkon Street, Yavne, Israel, 8122745
Analytics
WallStreet Target Price
30.67 USDP/E Ratio
–Dividend Yield
–Financials MDWD
Results | 2019 | Dynamics |